Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads

被引:37
作者
Hauser, RG
Cannom, D
Hayes, DL
Parsonnet, V
Hayes, J
Ratliff, N
Tyers, GFO
Epstein, AE
Vlay, SC
Furman, S
Gross, J
机构
[1] Minneapolis Heart Inst Fdn, Minneapolis, MN USA
[2] Good Samaritan Hosp, Los Angeles, CA USA
[3] Mayo Clin, Rochester, MN USA
[4] Newark Beth Israel, Newark, NJ USA
[5] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA
[6] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] Univ Hosp Stony Brook, Stony Brook, NY USA
[9] Montefiore Med Ctr, Bronx, NY 10467 USA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2002年 / 25卷 / 06期
关键词
implantable cardioverter defibrillator; leads; complications; registry;
D O I
10.1046/j.1460-9592.2002.t01-1-00879.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transvene models 693616966, a coaxial polyurethane ICD lead, may be prone to structural failure. These models comprise 54% of ICD lead failures in the authors' Multicenter Registry database. Because ICD leads perform a vital function, the clinical features, causes, and probability of Transvene 693616966 lead failure were determined. The Registry and United States Food and Drug Administration databases were queried for the clinical features and structural causes of the Transvene 693616966 lead failure, and a five-center substudy estimated the survival probability for 521 Transvene 6936/6966 implants. The mean time to failure was 4.8 +/- 2.1 years, and the estimated survival at 60 and 84 months after implant were 92% and 84%, respectively. Oversensing was the most common sign of failure (76%), and 24 patients experienced inappropriate shocks. The manufacturer's reports indicated that high voltage coil fracture and 80A polyurethane defects were the predominant causes of lead failure. Transvene models 6936 and 6966 coaxial polyurethane ICD leads are prone to failure over time. Patients who have these leads should be evaluated frequently, Additional studies are needed to identify safe management strategies.
引用
收藏
页码:879 / 882
页数:4
相关论文
共 50 条
  • [1] Long-Term Evaluation of Biotronik Linox and Linoxsmart Implantable Cardioverter Defibrillator Leads
    Good, Eric D.
    Cakulev, Ivan
    Orlov, Michael V.
    Hirsh, David
    Simeles, John
    Mohr, Kelly
    Moll, Phil
    Bloom, Heather
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (06) : 735 - 742
  • [2] Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads
    Borleffs, C. Jan Willem
    van Erven, Lieselot
    van Bommel, Rutger J.
    van der Velde, Enno T.
    van der Wall, Ernst E.
    Bax, Jeroen J.
    Rosendaal, Frits R.
    Schalij, Martin J.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (04) : 411 - 416
  • [3] Long-term evaluation of a novel extravascular implantable cardioverter defibrillator
    Gebran, Anthony
    Refaat, Marwan M.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (09) : 2379 - 2380
  • [4] Long-term clinical outcomes in implantable cardioverter defibrillator recipients on the island of Crete
    Kanoupakis, Emmanuel M.
    Fanourgiakis, John A.
    Mavrakis, Hercules E.
    Kallergis, Eleutherios M.
    Simantirakis, Emmanuel N.
    Crysostomakis, Stavros I.
    Saloustros, Ilias G.
    Chlouverakis, Gregory I.
    Vardas, Panos E.
    Hellenic Journal of Cardiology, 2016, 57 (04) : 247 - 252
  • [5] Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
    Uslu, Abdulkadir
    Dogan, Cem
    Duman, Hakan
    Tanboga, Ibrahim Halil
    Askin, Lutfu
    Sevimli, Serdar
    NORTHERN CLINICS OF ISTANBUL, 2019, 6 (01) : 40 - 47
  • [6] Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads
    Hauser, Robert G.
    Abdelhadi, Raed
    McGriff, Deepa
    Retel, Linda Kallinen
    HEART RHYTHM, 2012, 9 (08) : 1227 - 1235
  • [7] Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: the authors' own experience with optimal implantable cardioverter-defibrillator programming
    Lewandowski, Michal
    Sterlinski, Maciej
    Maciag, Aleksander
    Syska, Pawel
    Kowalik, Ilona
    Szwed, Hanna
    Chojnowska, Lidia
    Przybylski, Andrzej
    EUROPACE, 2010, 12 (09): : 1245 - 1250
  • [8] Comparison of outcomes in patients with abandoned versus extracted implantable cardioverter defibrillator leads
    Amelot, Mathieu
    Foucault, Anthony
    Scanu, Patrice
    Gomes, Sophie
    Champ-Rigot, Laure
    Pellissier, Arnaud
    Milliez, Paul
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2011, 104 (11) : 572 - 577
  • [9] Long-term incidence of upper extremity venous obstruction in implantable cardioverter defibrillator patients
    Horlbeck, Fritz W.
    Eckerth, Christopher
    Linhart, Markus
    Schaefer, Christian
    Jakob, Mark
    Pingel, Simon
    Klarmann-Schulz, Ute
    Nickenig, Georg
    Schwab, Joerg O.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (06): : 1027 - 1032
  • [10] Prospective Assessment of Linox Implantable Cardioverter Defibrillator Leads for Structural or Electrical Abnormalities
    McKeag, Nicholas A.
    Noad, Rebecca L.
    Ashfield, Kyle
    Wilson, Carol M.
    McEneaney, David J.
    Roberts, Michael J. D.
    ADVANCES IN THERAPY, 2018, 35 (05) : 666 - 670